PTIX - Protagenic Therapeutics, Inc.\new
0.74
-0.560 -75.676%
Share volume: 1,922,073
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.30
-0.56
-0.43%
Summary score
70%
Profitability
53%
Dept financing
47%
Liquidity
40%
Performance
100%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2022 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-38.77%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
60.29%
Debt ratio change over timeo
0%
Current Ratio
3.58%
Quick Ratio
0.32%
Cash Position Ratio
0.77%
Short-term ratios 30-Sep-2025 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
15.64%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
173.98%
Debt ratio change over timeo
0%
Current Ratio
0.32%
Quick Ratio
0.32%
Cash Position Ratio
0.3%
Last quarter ratios 30-Sep-2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
49.35%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
154%
Debt ratio change over time
0%
Current Ratio
0.34%
Quick Ratio
0.34%
Cash Position Ratio
0.32%
Performance ratios (change over 4 years) 30-Sep-2022 - 30-Sep-2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PTIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 9.15% | 14.43% | 0% |
| Return on assets | -38.77% | 4.82% | 3.1% | 1.47% |
| Return on sales | 0% | 31.37% | 24.99% | 22.8% |
| Return on invested capital | 0% | 6.63% | 14.96% | 0% |
| Profitability | 0% | 77% | 86% | 26% |
| Total debt ratio | 60.29% | 80.4% | 59.81% | 95.26% |
| Debt ratio change over time | 0% | -41.76% | -155.51% | 0% |
| Dept financing | 41% | 21% | 16% | 25% |
| Current Ratio | 0.32% | 1.58% | 1.03% | 0.67% |
| Quick Ratio | 0.32% | 1.19% | 0.77% | 0.56% |
| Cash Position Ratio | 0.3% | 0.21% | 0.36% | 0.12% |
| Liquididy | 58% | 38% | 44% | 32% |
| Short-term ratios | PTIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 15.64% | 7.35% | 2.48% | 2.48% |
| Return on sales | 0% | 43.41% | 22.09% | 27.34% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 37% | 17% | 20% |
| Total debt ratio | 173.98% | 76.43% | 59.07% | 102.44% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 11% | 8% | 15% |
| Current Ratio | 0.32% | 1.58% | 1.03% | 0.67% |
| Quick Ratio | 0.32% | 1.19% | 0.77% | 0.56% |
| Cash Position Ratio | 0.3% | 0.21% | 0.36% | 0.12% |
| Liquididy | 33% | 65% | 57% | 31% |